Back
Viridian Therapeutics, Inc. Stock Price Chart
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
33
VRDN
Viridian Therapeutics, Inc.
Last Price:
$18.82
Seasonality Move:
6.62%
7 Day Trial
ALL ACCESS PASS
$
7
-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and VRDN is experiencing slight selling pressure.
Viridian Therapeutics, Inc. Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 23.4 | Sell |
| 20-day SMA: | 26.38 | Sell |
| 50-day SMA: | 28.72 | Sell |
| 200-day SMA: | 24.45 | Sell |
| 8-day EMA: | 22.26 | Sell |
| 20-day EMA: | 25.26 | Sell |
| 50-day EMA: | 27.61 | Sell |
| 200-day EMA: | 25.4 | Sell |
Viridian Therapeutics, Inc. Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -2.4 | Sell |
| Relative Strength Index (14 RSI): | 23.54 | Sell |
| Chaikin Money Flow: | -18636 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (23.43 - 30.63) | Sell |
| Bollinger Bands (100): | (27.04 - 32.86) | Sell |
Viridian Therapeutics, Inc. Technical Analysis
| Mar 20 | Mar 23 | Mar 24 | Mar 25 | Mar 26 | Mar 27 | Mar 30 | Mar 31 | Apr 1 | Apr 2 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar | Apr | |||||||||
| 20 | 23 | 24 | 25 | 26 | 27 | 30 | 31 | 01 | 02 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Viridian Therapeutics, Inc. Stock
Is Viridian Therapeutics, Inc. Stock a Buy?
-
Viridian Therapeutics, Inc. share price is 18.84 while VRDN 8-day simple moving average is 23.40, which is a Sell signal.
-
The stock price of VRDN is 18.84 while Viridian Therapeutics, Inc. 20-day SMA is 26.38, which makes it a Sell.
-
Viridian Therapeutics, Inc. 50-day simple moving average is 28.72 while VRDN share price is 18.84, making it a Sell technically.
-
VRDN stock price is 18.84 and Viridian Therapeutics, Inc. 200-day simple moving average is 24.45, creating a Sell signal.
VRDN Technical Analysis vs Fundamental Analysis
Sell
33
Viridian Therapeutics, Inc. (VRDN)
is a Sell
Is Viridian Therapeutics, Inc. a Buy or a Sell?
-
Viridian Therapeutics, Inc. stock is rated a SellThe current Viridian Therapeutics, Inc. [VRDN] share price is $18.84. The Score for VRDN is 33, which is 34% below its historic median score of 50, and infers higher risk than normal.
Viridian Therapeutics, Inc. Stock Info
Market Cap:
1.9B
Price in USD:
18.84
Share Volume:
3M
Viridian Therapeutics, Inc. 52-Week Range
52-Week High:
34.29
52-Week Low:
9.90
Sell
33
Viridian Therapeutics, Inc. (VRDN)
is a Sell
Viridian Therapeutics, Inc. Share Price Forecast
-
What is the Viridian Therapeutics, Inc. stock price today?The Viridian Therapeutics, Inc. stock price is 18.84 USD today.
-
Will VRDN stock go up or go down?Viridian Therapeutics, Inc.> share price is forecast to RISE/FALL based on technical indicators
-
Is Viridian Therapeutics, Inc. overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Viridian Therapeutics, Inc. is overvalued.
Is Viridian Therapeutics, Inc. Stock a Buy?
-
Viridian Therapeutics, Inc. share price is 18.84 while VRDN 8-day exponential moving average is 22.26, which is a Sell signal.
-
The stock price of VRDN is 18.84 while Viridian Therapeutics, Inc. 20-day EMA is 25.26, which makes it a Sell.
-
Viridian Therapeutics, Inc. 50-day exponential moving average is 27.61 while VRDN share price is 18.84, making it a Sell technically.
-
VRDN stock price is 18.84 and Viridian Therapeutics, Inc. 200-day simple moving average is 25.40, creating a Sell signal.
Fundamental Analysis of Viridian Therapeutics, Inc.
Is Viridian Therapeutics, Inc. a good investment?
-
Analysts estimate an earnings decrease this quarter of $0.05 per share, an increase next quarter of $0.13 per share, a decrease this year of $0.31 per share, and an increase next year of $1.66 per share.
Technical Analysis of Viridian Therapeutics, Inc.
Should I short Viridian Therapeutics, Inc. stock?
-
VRDN Moving Average Covergence Divergence (MACD) indicator is -2.4, suggesting Viridian Therapeutics, Inc. is a Sell
-
Viridian Therapeutics, Inc. Relative Strength Index (RSI) is 23.54, which suggest Viridian Therapeutics, Inc. is oversold
-
The Bollinger Bands (25) for Viridian Therapeutics, Inc. is (23.43 - 30.63), which suggest Viridian Therapeutics, Inc. is a Sell
-
The Bollinger Bands (100) for Viridian Therapeutics, Inc. is (27.04 - 32.86), which suggest Viridian Therapeutics, Inc. is a Sell
* Viridian Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.